Markets ended at five-week highs on renewed buying interest in pharma shares.
BSE Healthcare, Capital Goods, IT and Metal indices have gained between 1-2%
Monsanto India is locked in upper circuit of 10% at Rs 1,467, while BASF India surged 7% to Rs 698 on the BSE.
Meanwhile, Maruti Suzuki slips nearly 5% along with Wipro, HUL, RIL, HDFC Bank and Hero MotoCorp down 1-2%
The stock was down nearly 2% at Rs 796, its lowest level since August 28 last year.
Check out the trading strategies in Nifty, Maruti Suzuki, pharma shares, CNX IT, United Spirits and Midcap stocks to buy
Check out the technical trends in select stocks with Mohit Gaba, Independent analyst and trader
Markets contined to trade firm on renewed buying interest in pharma shares
Analyst at Karvy Stock Broking recommends "BUY" recommendation on the stock with price target at Rs 462 per share.
The stock has dipped over 4% to Rs 1,595 on the National Stock Exchange
Maruti Suzuki, Tata Steel, Wipro, M&M and HDFC Bank have slipped between 0.3-4%
Maruti Suzuki, Tata Steel, Wipro, M&M and HDFC Bank have gained between 0.3-2.5%
The company's pharmaceutical manufacturing facility at Montreal, Canada as 'Acceptable', says USFDA.
Analyst at Angel Broking maintain accumulate rating on the stock with a target price of Rs 3,008.
The two stocks will replace Jaiprakash Associates and Ranbaxy
The early indicator, SGX Nifty was trading at 6,350 up 11 points at 0830 hrs.
Loan restructuring pipelines and commentary on asset quality continues to be bearish for most banks
Some MFs preparing products targeted at eligible segment but admit to cost and other problems dampening their marketing
Nifty, Bank Nifty, Mahindra & Mahindra & Infosys
Volatility Index rises by more than 10%